Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Creative Medical Technology Holdings (CELZ) Debt to Equity (2016 - 2023)

Creative Medical Technology Holdings has reported Debt to Equity over the past 14 years, most recently at $0.0 for Q1 2023.

  • Quarterly Debt to Equity fell 36.89% to $0.0 in Q1 2023 from the year-ago period, while the trailing twelve-month figure was $0.0 through Mar 2023, down 36.89% year-over-year, with the annual reading at $0.0 for FY2022, 35.59% down from the prior year.
  • Debt to Equity was $0.0 for Q1 2023 at Creative Medical Technology Holdings, up from $0.0 in the prior quarter.
  • Over five years, Debt to Equity peaked at $0.0 in Q1 2022 and troughed at -$0.97 in Q4 2020.
  • The 5-year median for Debt to Equity is -$0.01 (2020), against an average of -$0.3.
  • Biggest five-year swings in Debt to Equity: plummeted 51398.73% in 2019 and later surged 109.78% in 2022.
  • Tracing CELZ's Debt to Equity over 5 years: stood at -$0.85 in 2019, then fell by 14.78% to -$0.97 in 2020, then skyrocketed by 100.14% to $0.0 in 2021, then tumbled by 35.59% to $0.0 in 2022, then grew by 7.04% to $0.0 in 2023.
  • According to Business Quant data, Debt to Equity over the past three periods came in at $0.0, $0.0, and $0.0 for Q1 2023, Q4 2022, and Q3 2022 respectively.